A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome
- PMID: 18424452
- DOI: 10.1093/hmg/ddn124
A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome
Abstract
The main clinical features of two siblings from a consanguineous marriage were progressive myoclonic epilepsy without intellectual impairment and a nephrotic syndrome with a strong accumulation of C1q in capillary loops and mesangium of kidney. The biochemical analysis of one of the patients revealed a normal beta-glucocerebrosidase activity in leukocytes, but a severe enzymatic deficiency in cultured skin fibroblasts. This deficiency suggested a defect in the intracellular sorting pathway of this enzyme. The sequence analysis of the gene encoding LIMP-2 (SCARB2), the sorting receptor for beta-glucocerebrosidase, confirmed this hypothesis. A homozygous nonsense mutation in codon 178 of SCARB2 was found in the patient, whereas her healthy parents were heterozygous for the mutation. Besides lacking immunodetectable LIMP-2, patient fibroblasts also had decreased amounts of beta-glucocerebrosidase, which was mainly located in the endoplasmic reticulum, as assessed by its sensitivity to Endo H. This is the first report of a mutation in the SCARB2 gene associated with a human disease, which, contrary to earlier proposals, shares no features with Charcot-Marie-Tooth disease both at the clinical and neurophysiological levels.
Similar articles
-
Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.Mol Genet Metab. 2014 Feb;111(2):84-91. doi: 10.1016/j.ymgme.2013.12.005. Epub 2013 Dec 11. Mol Genet Metab. 2014. PMID: 24389070 Free PMC article. Review.
-
Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase.Hum Mol Genet. 2010 Feb 15;19(4):563-72. doi: 10.1093/hmg/ddp523. Epub 2009 Nov 20. Hum Mol Genet. 2010. PMID: 19933215
-
A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced β-glucocerebrosidase activity.J Neurol Sci. 2014 Apr 15;339(1-2):210-3. doi: 10.1016/j.jns.2014.01.022. Epub 2014 Jan 23. J Neurol Sci. 2014. PMID: 24485911
-
Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: clinical report of two siblings.Seizure. 2011 Nov;20(9):738-40. doi: 10.1016/j.seizure.2011.06.018. Epub 2011 Jul 22. Seizure. 2011. PMID: 21782476
-
Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review.Seizure. 2018 Apr;57:80-86. doi: 10.1016/j.seizure.2018.03.015. Epub 2018 Mar 14. Seizure. 2018. PMID: 29605618 Review.
Cited by
-
Glomerular diseases: genetic causes and future therapeutics.Nat Rev Nephrol. 2010 Sep;6(9):539-54. doi: 10.1038/nrneph.2010.103. Epub 2010 Jul 20. Nat Rev Nephrol. 2010. PMID: 20644582 Review.
-
Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability.Biochemistry. 2009 Jun 9;48(22):4816-27. doi: 10.1021/bi9002265. Biochemistry. 2009. PMID: 19374450 Free PMC article.
-
Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.Mol Genet Metab. 2014 Feb;111(2):84-91. doi: 10.1016/j.ymgme.2013.12.005. Epub 2013 Dec 11. Mol Genet Metab. 2014. PMID: 24389070 Free PMC article. Review.
-
The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.Seizure. 2019 Oct;71:247-257. doi: 10.1016/j.seizure.2019.08.012. Epub 2019 Aug 23. Seizure. 2019. PMID: 31476531 Free PMC article. Review.
-
Glucocerebrosidase: Functions in and Beyond the Lysosome.J Clin Med. 2020 Mar 9;9(3):736. doi: 10.3390/jcm9030736. J Clin Med. 2020. PMID: 32182893 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
